Determining ICU Staffs Conceptions, Opinions, Views, Experiences and Reflection of Brain Death and Organ Donation
Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Oct 10, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding how healthcare professionals in the intensive care units (ICUs) think and feel about brain death and organ donation. The study will gather insights from nurses and doctors at the University Hospital Basel to learn about their beliefs, opinions, and experiences related to these important topics. By understanding their views, the researchers hope to improve communication and practices surrounding organ donation.
To participate, individuals must be nurses or physicians currently working in the ICU at the University Hospital Basel and willing to share their thoughts. Those who are not currently working in the ICU or do not consent to take part in the study will not be included. Participants can expect to share their personal experiences and reflections in a supportive environment, contributing to a better understanding of how healthcare staff perceive brain death and the process of organ donation.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Consenting nurses and physicians currently working in the intensive care unit (ICU) at the University Hospital Basel
- • Only nurses and physicians consenting to participate will be included
- Exclusion Criteria:
- • Nurses and physicians not currently working (any more) in the intensive care unit (ICU) at the University Hospital Basel
- • Nurses and physicians who do not consent
About University Hospital, Basel, Switzerland
The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basel, , Switzerland
Patients applied
Trial Officials
Raoul C. Sutter, Prof. Dr.
Principal Investigator
University Hospital, Basel, Switzerland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported